Authors:
DEGEORGE JJ
AHN CH
ANDREWS PA
BROWER ME
GIORGIO DW
GOHEER MA
LEEHAM DY
MCGUINN WD
SCHMIDT W
SUN CJ
TRIPATHI SC
Citation: Jj. Degeorge et al., REGULATORY CONSIDERATIONS FOR PRECLINICAL DEVELOPMENT OF ANTICANCER DRUGS, Cancer chemotherapy and pharmacology, 41(3), 1998, pp. 173-185
Citation: Jf. Contrera et Jj. Degeorge, IN-VIVO TRANSGENIC BIOASSAYS AND ASSESSMENT OF THE CARCINOGENIC POTENTIAL OF PHARMACEUTICALS, Environmental health perspectives, 106, 1998, pp. 71-80
Citation: Jf. Contrera et al., CARCINOGENICITY TESTING AND THE EVALUATION OF REGULATORY REQUIREMENTSFOR PHARMACEUTICALS, Regulatory toxicology and pharmacology, 25(2), 1997, pp. 130-145
Authors:
DEGEORGE JJ
AHN CH
ANDREWS PA
BROWER ME
CHOI YS
CHUN MY
DU T
DOO YLH
MCGUINN WD
PEI LQ
SANCILIO LF
SCHMIDT W
SHEEVERS HV
SUN CJ
TRIPATHI S
VOGEL WM
WHITEHURST V
WILLIAMS S
TAYLOR AS
Citation: Jj. Degeorge et al., CONSIDERATIONS FOR TOXICOLOGY STUDIES OF RESPIRATORY DRUG PRODUCTS, Regulatory toxicology and pharmacology, 25(2), 1997, pp. 189-193
Authors:
CHOUDARY J
CONTRERA JF
DEFELICE A
DEGEORGE JJ
FARRELLY JG
FITZGERALD G
GOHEER MA
JACOBS A
JORDAN A
MEYERS L
OSTERBERG R
RESNICK C
SUN CJ
TEMPLE RJ
Citation: J. Choudary et al., RESPONSE TO MONRO AND MEHTA PROPOSAL FOR USE OF SINGLE-DOSE TOXICOLOGY STUDIES TO SUPPORT SINGLE-DOSE STUDIES OF NEW DRUGS IN HUMANS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 265-267
Authors:
KELLOFF GJ
JOHNSON JR
CROWELL JA
BOONE CW
DEGEORGE JJ
STEELE VE
MEHTA MU
TEMECK JW
SCHMIDT WJ
BURKE G
GREENWALD P
TEMPLE RJ
Citation: Gj. Kelloff et al., APPROACHES TO THE DEVELOPMENT AND MARKETING APPROVAL OF DRUGS THAT PREVENT CANCER, Cancer epidemiology, biomarkers & prevention, 4(1), 1995, pp. 1-10
Citation: Jj. Degeorge, FOOD-AND-DRUG-ADMINISTRATION VIEWPOINTS ON TOXICOKINETICS - THE VIEW FROM REVIEW, Toxicologic pathology, 23(2), 1995, pp. 220-225
Authors:
BLACK LE
FARRELLY JG
CAVAGNARO JA
AHN CH
DEGEORGE JJ
TAYLOR AS
DEFELICE AF
JORDAN A
Citation: Le. Black et al., REGULATORY CONSIDERATIONS FOR OLIGONUCLEOTIDE DRUGS - UPDATED RECOMMENDATIONS FOR PHARMACOLOGY AND TOXICOLOGY STUDIES, Antisense research and development, 4(4), 1994, pp. 299-301
Authors:
NARIAI T
DEGEORGE JJ
GREIG NH
GENKA S
RAPOPORT SI
PURDON AD
Citation: T. Nariai et al., DIFFERENCES IN RATES OF INCORPORATION OF INTRAVENOUSLY INJECTED RADIOLABELED FATTY-ACIDS INTO PHOSPHOLIPIDS OF INTRACEREBRALLY IMPLANTED TUMOR AND BRAIN IN AWAKE RATS, Clinical & experimental metastasis, 12(3), 1994, pp. 213-225
Authors:
JONES CR
ARAI T
BELL J
RAPOPORT SI
DEGEORGE JJ
Citation: Cr. Jones et al., ARECOLINE STIMULATED INCORPORATION OF INTRAVENOUSLY ADMINISTERED H-3 ARACHIDONIC-ACID INTO RAT-BRAIN SUBCELLULAR-FRACTIONS, Journal of neurochemistry, 62, 1994, pp. 190000074-190000074